Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Weiser

Showing results (141-150 of 176) with videos related to

Pageof 18
Sort By:
Comprehensive Psychiatry|February 17, 2005
Sensitivity of ICD-10 diagnosis of psychotic disorders in the Israeli National Hospitalization Registry compared with RDC diagnoses based on SADS-LMark Weiser, Kyra Kanyas, Dolores Malaspina, et al.
The Journal of Clinical Psychiatry|August 3, 2022
Add-On Pramipexole for the Treatment of Schizophrenia and Schizoaffective Disorder: A Randomized Controlled TrialLinda Levi, Daisy Zamora, Igor Nastas, et al.
Schizophrenia Bulletin|February 21, 2025
Is it Possible To Identify Patients After Their First Hospitalization for a Psychotic Disorder Who Do Not Use Anti-Psychotics and are Not Later Rehospitalized?Amir Krivoy, Jari Tiihonen, Johnatan Nissan, et al.
The Lancet. Psychiatry|November 4, 2023
Efficacy and safety of TV-46000, a long-acting, subcutaneous, injectable formulation of risperidone, for schizophrenia: a randomised clinical trial in the USA and BulgariaJohn M Kane, Eran Harary, Roy Eshet, et al.
The Journal of Clinical Psychiatry|May 26, 2017
Raloxifene Plus Antipsychotics Versus Placebo Plus Antipsychotics in Severely Ill Decompensated Postmenopausal Women With Schizophrenia or Schizoaffective Disorder: A Randomized Controlled TrialMark Weiser, Linda Levi, Shimon Burshtein, et al.
Archives of General Psychiatry|July 4, 2012
Family history of schizophrenia and bipolar disorder as risk factors for autismPatrick F Sullivan, Cecilia Magnusson, Abraham Reichenberg, et al.
Psychological Medicine|October 14, 2020
Personality disorders and cause-specific mortality: a nationwide study of 2 million adolescentsShmuel Tiosano, Lucian Laur, Amir Tirosh, et al.
JAMA Psychiatry|August 1, 2019
Effect of Adjunctive Estradiol on Schizophrenia Among Women of Childbearing Age: A Randomized Clinical TrialMark Weiser, Linda Levi, Daisy Zamora, et al.
Plos One|January 6, 2016
Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized TrialRobert C Smith, Revital Amiaz, Tian-Mei Si, et al.
The Journal of Clinical Psychiatry|July 17, 2012
A multicenter, add-on randomized controlled trial of low-dose d-serine for negative and cognitive symptoms of schizophreniaMark Weiser, Uriel Heresco-Levy, Michael Davidson, et al.
Pageof 18

Showing results (141-150 of 176) with videos related to

Sort By:
Pageof 18
Comprehensive Psychiatry|February 17, 2005
Sensitivity of ICD-10 diagnosis of psychotic disorders in the Israeli National Hospitalization Registry compared with RDC diagnoses based on SADS-LMark Weiser, Kyra Kanyas, Dolores Malaspina, et al.
The Journal of Clinical Psychiatry|August 3, 2022
Add-On Pramipexole for the Treatment of Schizophrenia and Schizoaffective Disorder: A Randomized Controlled TrialLinda Levi, Daisy Zamora, Igor Nastas, et al.
Schizophrenia Bulletin|February 21, 2025
Is it Possible To Identify Patients After Their First Hospitalization for a Psychotic Disorder Who Do Not Use Anti-Psychotics and are Not Later Rehospitalized?Amir Krivoy, Jari Tiihonen, Johnatan Nissan, et al.
The Lancet. Psychiatry|November 4, 2023
Efficacy and safety of TV-46000, a long-acting, subcutaneous, injectable formulation of risperidone, for schizophrenia: a randomised clinical trial in the USA and BulgariaJohn M Kane, Eran Harary, Roy Eshet, et al.
The Journal of Clinical Psychiatry|May 26, 2017
Raloxifene Plus Antipsychotics Versus Placebo Plus Antipsychotics in Severely Ill Decompensated Postmenopausal Women With Schizophrenia or Schizoaffective Disorder: A Randomized Controlled TrialMark Weiser, Linda Levi, Shimon Burshtein, et al.
Archives of General Psychiatry|July 4, 2012
Family history of schizophrenia and bipolar disorder as risk factors for autismPatrick F Sullivan, Cecilia Magnusson, Abraham Reichenberg, et al.
Psychological Medicine|October 14, 2020
Personality disorders and cause-specific mortality: a nationwide study of 2 million adolescentsShmuel Tiosano, Lucian Laur, Amir Tirosh, et al.
JAMA Psychiatry|August 1, 2019
Effect of Adjunctive Estradiol on Schizophrenia Among Women of Childbearing Age: A Randomized Clinical TrialMark Weiser, Linda Levi, Daisy Zamora, et al.
Plos One|January 6, 2016
Varenicline Effects on Smoking, Cognition, and Psychiatric Symptoms in Schizophrenia: A Double-Blind Randomized TrialRobert C Smith, Revital Amiaz, Tian-Mei Si, et al.
The Journal of Clinical Psychiatry|July 17, 2012
A multicenter, add-on randomized controlled trial of low-dose d-serine for negative and cognitive symptoms of schizophreniaMark Weiser, Uriel Heresco-Levy, Michael Davidson, et al.
Pageof 18